Back to Agenda
InSilicoTrials Technologies Innovation Theater: Are Human Patients Needed for Clinical Trials, Tomorrow?
Session Chair(s)
InSilicoTrials
Italy
Chart your new horizons by pioneering on the edge of Gen AI-powered In Silico Data Modeling. Proven case studies will be shared in a panel session from regulatory, sponsor and CRO perspectives. Learn how InSilicoTrials has enhanced drug dosing, trial performance, and patient safety across targeted populations. Discover significant reductions in time and costs—achieving up to a 90% efficiency in specific R&D activities—while upholding the highest standards of patient safety.
Don't miss the chance to receive an autographed complimentary copy of the publication "Toward Good Simulation Practice," co-authored by our CEO, Luca Emili, with the contribution of 13+ FDA leaders. This book is a cornerstone in promoting reliable and efficient In Silico Trials solutions, reflecting a major stride in medical research and development.
Speaker(s)
Moderator
MaryAnne Rizk, PhD
Rizk Management Advisors, United States
Chief Executive Officer
Panelist
Jonathan Solomon Helfgott, MS
Johns Hopkins University, United States
Senior Lecturer, Faculty, & Program Coordinator,
Panelist
Luca Emili
InSilicoTrials, United States
CEO
Panelist
Adam Kaplin
Miralogx, United States
Chief Scientific and Clinical Innovation Officer
Have an account?